Kahn Brothers Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Kahn Brothers Group's OGN Position: Q3 2026 in Review
Kahn Brothers Group reduced its Organon & Co (OGN) stake by 47% in Q3 2026, selling an estimated $17.2M and leaving 1,408,069 shares worth $19.3M. The position accounts for 3.21% of the portfolio, ranked #13.
Kahn Brothers Group first reported a position in OGN in Q2 2021 and has held it in 22 quarters since. The position peaked at $38.6M in Q3 2025. 608 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- Kahn Brothers Group held 1,408,069 shares of Organon & Co worth $19.3M as of Q3 2026.
- Kahn Brothers Group sold 1,262,454 Organon & Co shares in Q3 2026, an estimated $17.2M.
- Organon & Co made up 3.21% of Kahn Brothers Group's portfolio in Q3 2026, its #13 holding.
- Kahn Brothers Group first reported a position in Organon & Co in Q2 2021 and has held it in 22 quarters since.
- Kahn Brothers Group's Organon & Co position peaked at $38.6M in Q3 2025.
- 608 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on Kahn Brothers Group's 13F filing for Q3 2026, filed 16 Nov 2026.